Structure Therapeutics Inc. - Common Stock (GPCR)

CUSIP: 86366E106

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
+1,976,064
Put/Call ratio
68%
SEC-reported price per share
$28.00
Indexed holders
155
Value change
+$86,587,271
Number of buys
78
Open additional details 1 more signal available
Number of sells
85
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
215,359,875

Security key

86366E106

Report period

Q3 2025

Indexed institutions

155

Top holders

10

Ownership snapshot

Top reported holders of GPCR - Structure Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
3/15
Latest evidence
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.4% 12 rows are not safely comparable across share classes. 13D/G row: Avoro Capital Advisors LLC Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 9.4%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.
Comparable ownership Top 3
Avoro Capital Advisors LLC 9.4%
Janus Henderson Group Ltd. 7.7%
Capital Research Global Investors 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Avoro Capital Advisors LLC
13D/G
9.4%
Reported 13D/G · 30 Sep 2025
$454,066,620
16,216,665 shares
$0 30 Sep 2025
Janus Henderson Group Ltd.
13D/G 13F
JANUS HENDERSON GROUP PLC · Company
7.7%
Reported 13D/G · 30 Sep 2025
$124,567,128
4,448,826 shares
-$3,477,040 30 Sep 2025
Capital Research Global Investors
13D/G
3.8%
Reported 13D/G · 31 Mar 2025
$168,218,991
6,492,435 shares
$0 31 Mar 2025
BVF PARTNERS L P/IL
3/4/5
10%+ Owner
—
denominator unverified
—
462,605 shares
— 10 May 2023
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$142,603,450
6,875,769 shares
— 30 Jun 2025
Deep Track Capital, LP
13F
Company
13F
—
denominator unverified
$106,477,439
5,133,917 shares
— 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
155
Shares
56,638,847
Indexed holders
155
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 indexed holders
172
Q3 2025 indexed holders
155
Indexed holder difference
-17
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .